Recent data from 2024 to 2026 highlights the significant cardiorenal benefits of both GLP-1 receptor agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2i), each excelling in distinct clinical aspects
They are supposed to transfer ingredients to the body over a controlled period of time
Key Facts A phase three clinical trial on Saxenda found suicidal thoughts were one of the drugs most severe side effectsother serious side effects include renal impairment, pancreatitis and gallbladder disease
Do GLP-1 Medications Help With Addiction
Trending on TikTok The rise of #PinkNailDesign and #BraidsAndBows highlights playful, creative styles, while #GenZMakeup favors fresh-faced, natural looks with fun touches like graphic eyeliner, pastels, and faux freckles
Pharmacoepidemiol Drug Saf (2015) 24(10):101725